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Objective: This study aimed to (1) identify trajectories of benefit finding in people with 
cancer receiving psychological care; (2) examine whether age, gender, education, years after 
diagnosis, and disease severity distinguished these trajectories; and (3) examine the 
associations of benefit finding trajectories with level and course of depressive and anxiety 
symptoms.  
 
Methods: Participants were 241 people with cancer who received psychological care at one of 
the seven psycho-oncology institutions in the Netherlands. Data were collected before the 
start of psychological care, and three months and nine months thereafter. A latent class 
growth analysis was performed to identify benefit finding trajectories. Chi-square tests and 
ANOVAs were performed for the second and third research questions.  
 
Results: Five benefit finding trajectories were identified: ‘high level-stable’ (8%), ‘very low 
level-small increase’ (16%), ‘low level-small increase’ (39%), ‘moderate level-small increase’ 
(29%), and ‘low level-large increase’ (8%). Perceived prognosis was found to distinguish 
these trajectories: people with a favourable prognosis were more likely to report consistently 
high levels of benefit finding over time, while people with an unfavourable/uncertain 
prognosis were more likely to experience a large increase in benefit finding. People who 
followed distinct benefit finding trajectories also reported differential courses of depressive 
symptoms, but not anxiety symptoms. Compared with the other four trajectories, people in the 
‘low level-large increase’ trajectory group reported the largest decreases in depressive and 
anxiety symptoms over time.  
 
Conclusions: People with cancer showed distinct trajectories of benefit finding while 
undergoing psychological care. Only a small proportion of them reported a large increase in 
benefit finding. This group also showed the largest improvements in psychological symptoms 










People with cancer may not only experience negative psychological outcomes (e.g., 
depressive and anxiety symptoms), but also positive outcomes (e.g., changes in life priorities, 
increased appreciation of life, and becoming a stronger person) (Arpawong, Richeimer, 
Weinstein, Elghamrawy, & Milam, 2013; Brix et al., 2013; Danhauer et al., 2013; Helgeson, 
2010; Schroevers, Kraaij, & Garnefski, 2011). In previous studies, these positive changes 
have been described using various terms, such as posttraumatic growth (Tedeschi & Calhoun, 
2004), stress-related growth (Park, Cohen, & Murch, 1996), and benefit finding (Affleck & 
Tennen, 1996). Because benefit finding seems to be the broadest term, this study used this 
term to encompass the range of positive changes reported by people with cancer.         
           Tedeschi and Calhoun (2004) suggest that benefit finding (which they referred to as 
post-traumatic growth) is the result of actively struggling with and cognitively processing 
stressful life events, and that it evolves over time as individuals become more able to process 
the stressors. Longitudinal studies in people with cancer have found that benefit finding 
develops soon after cancer diagnosis and increases in the first year after diagnosis (Danhauer 
et al., 2013; Liu, Wang, Wang, Su, & Wang, 2013; Manne et al., 2004). Previous studies also 
examined the course of benefit finding in people with cancer who were receiving 
psychological care. Increases in benefit finding were reported by people with cancer who 
received cognitive-behavioural stress management, which was not primarily designed to 
increase benefit finding (Antoni et al., 2001; Antoni et al., 2006; McGregor et al., 2004; 
Penedo et al., 2006).  
Calhoun and Tedeschi (2004) proposed that there may be different benefit finding 
trajectories over time in trauma survivors who engage in benefit finding, with some people 
reporting sustained and enhanced benefit finding and others reporting decreased benefit 
finding. However, as previous studies mainly examined average changes in benefit finding, 
few studies have addressed this assumption. One study in people with HIV found four distinct 
courses of benefit finding over an 18-month period in natural adaptation: ‘always reporting 
benefit’ (42%), ‘never reporting benefit’ (27%), ‘lost benefit’ (18%), and ‘gained benefit’ 
(13%) (Milam, 2004). To establish a better understanding of the differential courses of benefit 
finding in cancer patients receiving psychological care, this study first aimed to identify the 
distinct trajectories of benefit finding in this population.  
         Provided that distinct benefit finding trajectories can be identified, it is also important to 




demographic and medical characteristics with concurrent and future levels of benefit finding 
in people with cancer, but findings are inconsistent. Some studies found a higher benefit 
finding in those of a younger age (Bellizzi et al., 2010; Brix et al., 2013; Schroevers, 
Helgeson, Sanderman, & Ranchor, 2010), of a lower education level (Jansen, Hoffmeister, 
Chang-Claude, Brenner, & Arndt, 2011), who had a longer time since diagnosis (Brix et al., 
2013; Manne et al., 2004; Sears, Stanton, & Danoff-Burg, 2003), and who had more severe 
disease (Bellizzi et al., 2010). Conversely, other studies found a higher benefit finding in 
people of a higher education level (Sears, Stanton, & Danoff-Burg, 2003) and a shorter time 
since diagnosis (Zebrack et al., 2012). Few studies have examined the predictive value of 
these characteristics on changes in benefit finding. Based on previous literature, the present 
study specifically focused on age, gender, education, years since diagnosis, and disease 
severity (i.e., prognosis, metastases, and cancer recurrence), and examined whether these 
factors could distinguish distinct trajectories of benefit finding.   
          As Tedeschi and Calhoun (2004) perceive benefit finding as an independent outcome, 
they do not predict that benefit finding is related to psychological functioning in trauma 
survivors. Numerous studies have examined the relation of benefit finding to psychological 
functioning and produced inconsistent findings. In a meta-analysis of mainly cross-sectional 
studies, Helgeson, Reynolds, and Tomich (2006) found that benefit finding was associated 
with fewer depressive symptoms and more positive well-being, but also more intrusive and 
avoidant thoughts about the stressor. Benefit finding was not related to anxiety, global distress, 
or quality of life. Several more recent studies have also yielded mixed results. Several 
longitudinal studies in cancer patients found that a higher baseline level of benefit finding was 
associated with less future distress (Liu et al., 2013; Rinaldis, Pakenham, & Lynch, 2010), 
whereas other longitudinal studies found no association between benefit finding and future 
psychological symptoms (Llewellyn et al., 2013). One reason for these inconsistent findings 
could be that benefit finding is an on-going process that possibly has different meanings and 
effects on psychological functioning over time (Helgeson et al., 2006; Sawyer, Ayers, & Field, 
2010). Most empirical studies in people with cancer did not consider the possibility of 
different courses of benefit finding when examining the role of benefit finding on 
psychological functioning. Thus, a third aim of this study was to examine how distinct 
trajectories of benefit finding were associated with psychological symptoms.  
The first aim of this study was to examine whether distinct benefit finding trajectories 




oncological institutions. Based on the findings of Milam (2004), we expected to observe the 
following distinct benefit finding trajectories: one trajectory characterized by stably high 
benefit finding, one with stably low benefit finding, one with decreases in benefit findings, 
and one with increases in benefit finding. The second aim was to examine whether age, 
gender, education, years since diagnosis, and disease severity (i.e., prognosis, metastases, and 
cancer recurrence) could distinguish these trajectories. Type and duration of psychological 
care were also examined as predictors of trajectories. The third aim was to examine whether 
benefit finding trajectories were associated with the level and courses of depressive and 
anxiety symptoms. As previous studies did not examine the association of changes in benefit 
finding with the selected characteristics or with psychological symptoms, we had no specific 
hypothesis for the second and third aims. 
 
Methods 
Participants and procedure 
Participants were people with cancer who sought help at one of the seven specialized psycho-
oncology institutions in the Netherlands between September 2008 and March 2010. When 
patients sought psychological care at one of these institutions, they were provided with 
information about the current research. Inclusion criteria were as follows: (1) diagnosed with 
cancer and seeking help, (2) older than 18 years, and (3) able to complete questionnaires in 
Dutch.                
           A total of 611 persons were contacted about this study, and 524 agreed to participate 
and provided written informed consent. The 87 people who declined did not differ 
significantly from the 524 people who consented with respect to age or gender. Of the 524 
people, only 384 completed the baseline assessment before psychological care (T1), because 
123 people dropped out, nine did not complete the baseline measurement, and eight changed 
their minds about undergoing psychological care. There were no significant differences in age 
or gender between the 384 participants and the 140 non-participants. Of the 384 people, 278 
(72%) completed the second assessment after three months (T2), and 241 (63%) completed 
the third assessment after nine months (T3). Compared to those 241 people, the 143 drop-outs 
were less educated, more likely to be male, more likely to have an unfavourable prognosis, 
and less likely to have received an operation (p < 0.05). There were no significant differences 
in baseline levels of benefit finding or depressive and anxiety symptoms between the 241 




missed the T2 measurement. As the analyses could be performed despite missing data, these 
26 people were included.  
 
Measures 
Socio-demographic and medical characteristics (e.g., age, educational level, cancer type, 
perceived prognosis) were assessed via self-report questionnaire at T1. Educational level was 
divided into three categories: low = primary/lower vocational, middle = secondary/middle 
vocational, and high = university /higher vocational. Patients indicated that they perceived 
their prognosis as one of the following: favourable, unfavourable, or uncertain.  
          Psychological care characteristics were obtained using a self-report questionnaire at T2 
and T3. Psycho-oncology institutions offered the following different types of psychological 
care:  individual therapy, group therapy, and other therapy (e.g., haptonomy). As each 
participant may have received more than one type of therapy, psychological care was 
classified into four categories: individual, group, individual and group, and other (all 
with/without other therapy). Patients also reported whether they had completed psychological 
care at T2 and T3, separately.  
          Benefit finding was measured with the ‘perceived benefits’ subscale of the Illness 
Cognition Questionnaires for chronic diseases (Evers et al., 2001). This 18-item questionnaire 
comprises three six-item subscales: acceptance, helplessness, and perceived benefits. The 
perceived benefits subscale measures the extent to which people perceive benefits from 
disease. A sample item is ‘I have learned a great deal from my illness’. Each item can be 
answered on a 4-point scale ranging from 1 (‘not at all’) to 4 (‘completely’). Total score 
ranges from 6 to 24, with higher scores indicating greater perceived benefit. An average score 
of 16 was previously reported for people with cancer (Bossema et al., 2011). The perceived 
benefits subscale has good validity and reliability (Evers et al., 2001). In this study, 
Cronbach’s α coefficients ranged from 0.87 to 0.88.  
         Depressive symptoms were measured with the 16-item version of the Center for 
Epidemiologic Studies Depression Scale (CES-D) (Radloff, 1977). This version was found to 
be a more valid measure of depressive symptoms in people with cancer (Schroevers, 
Sanderman, van Sonderen, & Ranchor, 2000). A sample item is ‘I felt depressed’. Items were 
answered on a 4-point scale ranging from 0 (<1 day) to 3 (5–7 days). Total score ranges from 




reliability and validity were reported in people with cancer (Schroevers et al., 2000). In this 
study, Cronbach’s α coefficients ranged from 0.88 to 0.91.              
          Anxiety symptoms were measured with the six-item version of the State-Trait Anxiety 
Inventory (STAI) (Marteau & Bekker, 1992; Spielberger, Gorsuch, & Lushene, 1970). A 
sample item is ‘I am confused’. Items are answered on a 4-point scale ranging from 1 (‘not at 
all’) to 4 (‘very much’). Total score ranges from 6 to 24, with higher scores indicating higher 
anxiety. This version of the STAI has been found to have good reliability and validity 
(Marteau & Bekker, 1992). In this study, Cronbach’s α coefficients ranged from 0.84 to 0.86. 
 
Statistical analysis 
General Linear Modelling (GLM) was performed using SPSS 20.0 to examine average 
changes in benefit finding and psychological symptoms. Cohen’s d was calculated to measure 
the magnitude of change. Pearson’s correlation analysis was used to examine the relationship 
between changes in benefit finding and psychological symptoms over time.            
         To identify distinct trajectories of benefit finding, a latent class growth analysis (LCGA) 
with robust maximum likelihood estimation was performed in Mplus 7.1 (Muthén and 
Muthén, 1998-2012). LCGA can be used to identify unobserved differences in growth 
trajectories over time, and can estimate the intercepts, and the linear and quadratic slopes for 
each latent class (Nagin, 1999). This study tested models that ranged from one to six classes. 
Several criteria were used to determine the best representative model. First, the following 
statistical criteria were checked: the Bayesian Information Criterion (BIC), the Akaike 
Information Criterion (AIC), entropy, the Bootstrap Likelihood Ratio Test (BLRT), and the 
Vuong-Lo-Mendell-Rubin likelihood ratio test (VLMR). The BIC and AIC are measures of 
the relative fit of different models, and lower BIC and AIC values indicate a better fit. 
Entropy was used to inspect latent class separation. A model with a higher entropy (at least 
0.6) is considered to have better class separation (Asparouhov & Muthén, 2013). The BLRT 
and VLMR were used to test whether a model with ‘K classes’ is better than a model with ‘K-
1 classes’ (Jung & Wickrama, 2008; Nylund, Asparoutiov, & Muthén, 2007). Significant 
BLRT and VLMR indicate that the ‘K classes’ model is better than the ‘K-1 classes’ model 
(Jung & Wickrama, 2008; Nylund et al., 2007). Second, several non-statistical criteria were 
used to select a model. The addition of one extra class should be conceptually meaningful and 
represent a class that is clearly different from other classes in the model with fewer classes. 




et al., 2007). The analytic procedure in Mplus applies the Full Information Maximum 
Likelihood and the Expectation Maximization Algorithm, which assumes that missing data 
can be ignored (Muthén, 2002). To examine whether the missing data affected the model 
selection results, the LCGA was repeated for those 205 people with complete data. According 
to the selected model, each participant was assigned to a trajectory group based on the latent 
class posterior distribution. This membership was exported to SPSS and used to represent 
trajectories of benefit finding in the following analysis in SPSS. In order to describe changes 
in benefit finding for each trajectory group, separate GLMs on benefit finding over time were 
performed within each trajectory group. 
          To determine whether trajectories differed from one another on the selected 
characteristics, Chi-square tests and ANOVAs were used to compare the trajectories for each 
variable. To examine whether benefit finding trajectories were related to the course of 
psychological symptoms, interaction effects between trajectories and time were examined in 
GLM for depressive and anxiety symptoms in the entire sample. Second, to examine whether 
benefit finding trajectories were related to levels of psychological symptoms across time, one-
way ANOVAs were performed for each time point. Third, to describe changes in 
psychological symptoms over time within each trajectory, separate GLMs were performed on 




The socio-demographic, medical, and psychological care characteristics of the 241 
participants are shown in Table 1. Mean age was 51.39, approximately 80% were women, and 
50% were highly educated. Almost half of the patients had been diagnosed with breast cancer, 
and around half of the participants had received individual psychological therapy 
(with/without additional other therapy).  
 
Average changes in benefit finding and psychological symptoms in the entire sample 
The mean scores of benefit finding, depressive symptoms, and anxiety symptoms at T1, T2, 
and T3 are shown in Table 2. There were significant increases in benefit finding over time, 
mainly from T1 to T2. Symptoms of depression and anxiety decreased significantly from T1 




significantly correlated with decreases in depressive (r = -0.34, p < 0.01) and anxiety 
symptoms (r = -0.31, p < 0.01) over the same period. 
 
 
Table 1. Socio-demographic and medical characteristics of the study sample 
   Mean (SD) 
Age  (in years) 
 







25 – 79 
  3.29 (5.72) 
 1 – 36 
 
            % (n) 
Gender Male    19.9% (48) 
 Female    80.1% (193) 
Relationship Yes    79.7% (192) 
 No 
Missing 
   19.1% (46) 
     1.2% (3) 
Educational Level Low    17.4% (42)  
 Middle    32.0% (77) 
 High 
Missing 
   49.0% (118) 
     1.7% (4) 
Cancer type Breast     45.6% (110) 
 Digestive system       7.1% (17) 
 Lung       2.9% (7) 
 Hematologic       8.7% (21) 
 Head and neck       6.2% (15) 
 Gynecological       5.8% (14) 
 Multiple malignant       7.9% (19) 
 Others 
Missing 
   14.9% (36) 
     0.8% (2) 
Under medical treatment Yes    49.8% (119) 
Type of medical  Operation    15.8% (38) 
treatment Chemotherapy      8.3% (20) 
 Radiotherapy      2.1% (5) 
 Operation + Chemotherapy    20.7% (50) 
 Operation + Radiotherapy     17.0% (41) 
 Chemotherapy + Radiotherapy  
Operation + Chemotherapy  
+ Radiotherapy 
     5.4% (13) 
   24.5% (59) 
 Other       6.2% (15) 
Recurrence Yes    14.1% (34) 
Metastases Yes 
 
   31.9% (77) 
 






Identification trajectories of benefit finding 
As can be seen in Table 3, the BIC suggested that the 4-class model was the best, whereas the 
AIC favoured the 6-class model. However, the BLRT and the VLMR suggested that the 5-
class model was best: the significant BLRT and VLMR indicated that the 5-class model was 
better than the 4-class model, and the non-significant BLRT and VLMR showed that the 6-
class model was not better than the 5-class model. Furthermore, the 5-class model had the 
highest entropy, indicating it had the best class separation. In addition, for the 5-class model, 
the smallest group contains a substantial number of the total sample (8%). Therefore, the 5-
class model was chosen to represent benefit finding trajectories.  
          We performed the same analysis in those 205 patients with complete data. Similarly, a 
5-class model was found to be best. This model reflected the same five trajectories of benefit 
finding as examined in the full sample. The class size (38%, 30%, 15%, 9%, and 8%) was 
also comparable to the model in the full sample (39%, 29%, 16%, 8%, and 8%). Thus, it can 
be concluded that missing data did not impact the results of model selection.    
          The parameter estimates for the 5-class model are shown in Table 3. Mean levels of 
benefit finding for each trajectory group are shown in Table 2 and Figure 1. Class 1 (‘high 
level-stable group’, 8%) started out with a high level of benefit finding at T1 and remained 
relatively stable in benefit finding from T1 to T3. Class 2 (‘very low level-small increase 
group’, 16%), Class 4 (‘low level-small increase group’, 39%), and Class 3 (‘moderate level-
small increase group’, 29%) started out with very low, low, and moderate levels of benefit 
finding at T1, respectively. They all showed small increases in benefit finding from T1 to T2 
and remained stable until T3. Class 5 (‘low level-large increase group’, 8%) started out with a 
low level of benefit finding at T1 and reported large increases in benefit finding between T1 
and T2, and remained at a high level of benefit finding until T3.  
 
Predictors of benefit finding trajectories 
As shown in Table 4, perceived cancer prognosis was the only factor that distinguished 
benefit finding trajectories (p < 0.05). Patients with a favourable prognosis were more likely 
to belong to Class 1 (‘high level-stable group’), whereas those with an unfavourable/uncertain 










Table 2. Means and SDs of benefit finding, depression, and anxiety at T1, T2, and T3 in the whole 



















































































  7.69** 0.48 
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  9.02 
(6.57) 
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(6.22) 
  6.28 
(4.59) 
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  9.64 
(1.86) 




























































































Note: *p < .05; **p < .01; ***p < .001; 
a 
Separate GLMs were conducted to examine the course of 
benefit finding, depressive and anxiety symptoms in SPSS. Given that SPSS used a Listwise 
deletion of the missing values in the GLM, all GLM analyses in this table were performed among 
those patients with complete data (benefit finding: n = 205; depressive symptoms: n = 206; 
anxiety symptoms: n = 205) 
 
  





BLRT VLMR Class Prevalence 
1 2 3 4 5 6 
1 3985.58 3964.67 n/a     n/a      n/a 100%      
2 3771.55 3736.71 0.77 235.97*** 235.97*** 51% 49%     
3 3710.29 3661.50 0.77   83.21*** 83.21** 26% 46% 28%    
4 3702.36 3639.63 0.77   29.87***   29.87  21% 34% 10% 35%   
5 3705.49 3628.83 0.80   18.80***   18.80*    8% 16% 29% 39%   8%  
6 3716.04 3625.43 0.76   11.40
ns
   11.40
ns
    8% 15%   7% 34% 28% 8% 
 
Parameter estimates for the selected five-class model 
 
 
    Intercept 
   M (SE) 
    Slope 
 M (SE) 
 Quadratic 
 M (SE) 
 
 
Class 1 21.91 (0.91)***  0.17 (0.40)    -0.01 (0.04)  
Class 2   8.55 (0.40)***  0.57 (0.20)** -0.04 (0.02)  
Class 3 17.91 (0.34)***  0.51 (0.19)** -0.05(0.02)**  
Class 4 12.78 (0.37)***  0.65 (0.24)** -0.05 (0.02)*  
Class 5 12.55 (0.66)***  2.65 (0.50)*** -0.21 (0.04)***      




The association of benefit finding trajectories with psychological symptoms 
ANOVAs showed that the levels of psychological symptoms differed between benefit finding 
trajectories at T1 [depression: F(4, 231) = 5.16, p < 0.01; anxiety: F(4, 232) = 5.01, p < 0.01], 
at T2 [depression: F (4, 208) = 4.61, p < 0.01; anxiety: F(4, 206) = 5.65, p < 0.001], and at T3 
[depression: F (4, 233) = 3.79, p < 0.01; anxiety: F (4, 233) = 7.13, p < 0.001]. Trajectories 
characterized by higher benefit finding levels were associated with fewer depressive and 
anxiety symptoms across time. 
          The courses of depressive and anxiety symptoms for all five benefit finding trajectories 
are shown in Table 2 (also see Figure 2-3). Patients with distinct benefit finding trajectories 
reported differential courses of depressive symptoms [Ftime×group (7.62, 382.81) = 2.39, p < 
0.05], but did not report differential courses of anxiety symptoms [Ftime×group (7.49, 374.61) = 
10.10, n.s.]. For depressive symptoms, the three groups with small increases in benefit finding 
from T1 to T2 (Classes 2, 3, and 4) reported small to moderate decreases in depressive 
symptoms in the same time period. The group with the largest increases in benefit finding 
(Class 5) reported the largest decreases in depressive symptoms in the same period of time. 
The group with stably high benefit finding (Class 1) maintained stable low levels of 
depressive symptoms. For anxiety symptoms, patients in the four groups with small to 
moderate increases in benefit finding (Classes 2, 3, 4, and 5) all reported moderate to large 
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Figure 2. Observed levels and courses of depressive symptoms at each benefit finding 





Figure 3. Observed levels and courses of anxiety symptoms at each  benefit finding trajectory 
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Table 4. Predictors of patients with distinct benefit finding trajectories 
Predictor Total 
Sample 









 M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) ANOV
A/ χ2 









































Gender (% woman) 80.0% 88.9% 79.5% 82.6% 78.1% 73.7% n.s. 
Educational Level 
  Low 
  Middle 



























Metastases (% yes) 31.9% 11.1% 33.3% 40.6% 29.0% 31.6% n.s. 
Perceived prognosis        
  Favorable  50.8% 82.4% 43.6% 43.5% 56.3% 36.8% χ2 =  
  Unfavorable 12.1% 11.8% 20.5% 14.5%   7.3% 10.5% 16.42, 
  Uncertain 37.1%   5.9% 35.9% 42.0% 36.5% 52.6% p < .05 
Recurrence (% yes) 14.1% 11.1% 17.9% 17.4% 11.5% 10.5% n.s. 
Type of psychological    
care (T1-T2)  
       
  Individual   58.5% 50.0% 51.3% 62.3% 58.3% 68.4% n.s. 
  Group  8.3% 5.6% 17.9% 5.8% 6.3% 10.5%  
  Individual + Group  14.5% 22.2% 7.7% 15.9% 13.5% 21.1%  
  Other 2.1% 0.0% 2.6% 2.9% 2.1% 0.0%  
  Missing 16.6% 22.2% 20.5% 13.0% 19.8% 0.0%  
Psychological care 





















Type of psychological    
 care (T2 - T3)
a
 
       
  Individual   52.1% 53.8% 50.0% 52.6% 51.3% 57.1% n.s. 
  Group    4.3%   7.7%  3.6%  3.5%   3.9%   7.1%  
  Individual + Group  23.9% 23.1% 14.3% 28.1% 25.0% 21.4%  
  Other    1.6%   7.7%   0.0%   0.0%   2.6%   0.0%  
  Missing 18.1%   7.7% 32.1% 15.8% 17.1% 14.3%  
Psychological care 






















Types of psychological care were reported by those 187 patients who were under 









Discussion         
This is the first study to identify benefit finding trajectories in people with cancer during 
psychological care. Five distinct benefit finding trajectories were identified: ‘high level-stable’ 
(8%), ‘very low level-small increase’ (16%), ‘low level-small increase’ (39%), ‘moderate 
level-small increase’ (29%), and ‘low level-large increase’ (8%). Perceived cancer prognosis 
was the only factor that distinguished these trajectories: people with a favourable prognosis 
were more likely to maintain stably high levels of benefit finding, and people with an 
unfavourable/uncertain prognosis were more likely to report large increases in benefit finding. 
The five benefit finding trajectories were significantly related to levels of depressive and 
anxiety symptoms across time, and to differential courses of depressive symptoms.  
           Despite that five benefit finding trajectories were identified, a closer look revealed that 
the five trajectories displayed three main patterns over time. The vast majority of people (i.e., 
84%) showed small increases in benefit finding, with people in these three trajectories mainly 
differing in their absolute levels of benefit finding. A small group (i.e., 8%) started with a low 
level of benefit finding and reported large increases in benefit finding. Another small group 
(i.e., 8%) started with high levels of benefit finding and maintained this level over time. The 
finding that the majority showed small increases in benefit finding and another small group 
showed large increases is consistent with previous findings in people with cancer receiving 
psychological care, in which small to moderate increases in benefit finding were observed in 
all patients (Antoni et al., 2006; Penedo et al., 2006). The present findings add to these studies 
by showing that differential patterns of benefit finding can be observed during psychological 
care, with regard to level and course of benefit finding over time.  
           The five trajectories of benefit finding are partly in line with those observed in a study 
of people with HIV (Milam, 2004). Our ‘high level-stable’ trajectory in people with cancer 
was similar to their ‘always reporting benefit’ trajectory in people with HIV, and the other 
four trajectories characterized by small to large increases in our study resembled their ‘gained 
benefit’ trajectory. In contrast, the current study of people with cancer did not reveal a group 
characterized by loss-of-benefit over time. One explanation for this might be that the current 
study focused on people with cancer who were receiving psychological care, whereas the 
Milam study was conducted in people with HIV within the context of natural adaptation. If 
this is the case, psychological care might pre-empt the worsening of benefit finding. Yet, the 
lack of a control group and the randomized design in this study does not permit such a firm 




regarding benefit finding trajectories in people with cancer, together with the findings in 
people with HIV, confirm the assumption of Calhoun and Tedeschi (2004) and provide 
empirical evidence for the differential processes of benefit finding over time in people with 
life-threatening diseases. This warrants further research into the distinct trajectories of benefit 
finding in survivors of other types of trauma.  
             Perceived cancer prognosis was the only factor that significantly differentiated benefit 
finding trajectories. First, most patients who exhibited a large increase in benefit finding had 
an unfavourable or uncertain prognosis. This is consistent with the theories of Tedeschi and 
Calhoun (2004), assuming that a search for benefit is provoked by a severe and threatening 
trauma that is crucial enough to challenge one’s own beliefs and assumptions about the world 
(Tedeschi & Calhoun, 2004). As for people with cancer, those with a more severe form of 
cancer are often confronted with a higher likelihood of mortality and prolonged medical 
treatments, which are likely to facilitate benefit finding (Stanton, Bower, & Low, 2006). 
Second, the majority of people with consistently high levels of benefit finding reported a 
favourable prognosis. People with a less severe form of cancer may not experience many 
physical problems, which may allow for the mobilization of individual resources that could 
produce positive changes (Collins, Taylor, & Skokan, 1990). However, this seems to conflict 
with the theories of Tedeschi and Calhoun. Thus, these puzzling findings warrant further 
research on this topic. Moreover, it should be noted that, in this study, the documented 
prognosis was based on patient self-report, which was a subjective indicator of disease 
severity. Yet, two other objective indicators of disease severity (metastases and cancer 
recurrence) were not found to significantly distinguish benefit finding trajectories. Thus, it 
seems that how people perceive their cancer severity plays a more important role in the 
process of benefit finding than does actual disease severity. Future research could examine to 
what extent perceived and actual cancer severity differ from each other (and the possible 
interaction between the two) in predicting differential processes of benefit finding. 
            In addition, although none of the other measured characteristics significantly 
distinguished benefit finding trajectories, people with consistently high levels of benefit 
finding tended to be younger, female, and less likely to report metastases than people 
categorized into one of the other four trajectories. These non-significant findings might have 
been resulted from the relatively small sample size of this study. Specifically, the ‘high level-
stable’ and ‘low level-large increase’ trajectories contained only a small number of patients, 




significant predictors. Future studies with a larger sample size are needed to further examine 
the predictive value of these factors for benefit finding trajectories. Another explanation for 
the null findings could be that the five trajectories of benefit finding were not that distinct 
from each other, given that most participants experienced a general increase in benefit finding 
over time.                 
           Trajectories of benefit finding were associated with levels of depressive and anxiety 
symptoms. Compared to people in other trajectories, those people with consistently high or 
large increases in benefit finding reported fewer depressive and anxiety symptoms after three 
and nine months. This is consistent with findings from people with HIV in that those who 
always experienced or gained benefit reported less depression than did those who never 
experienced or lost benefit (Milam, 2004). These findings suggest that the development and 
maintenance of benefit finding are associated with better psychological functioning. Notably, 
theoretical models do not substantially consider the adaptive effect of benefit finding on 
psychological functioning. For example, Tedeschi and Calhoun (2004) propose that benefit 
finding and psychological functioning are independent of each other. As such, benefit finding 
does not necessarily relate to improved psychological functioning. The present findings are 
contradictory to this supposition, as this study suggest a clear association between benefit 
finding and psychological functioning.   
            Patients with distinct benefit finding trajectories reported differential courses of 
depressive, but not anxiety symptoms. The courses of depressive symptoms showed similar 
but opposite patterns to the five trajectories of benefit finding. This could be explained by the 
reciprocal relationship between benefit finding and depressive symptoms, as proposed by 
Milam (2006). On the one hand, the presence of depressive symptoms usually comes together 
with less joy and more negative thoughts, which may impede the development of benefit 
finding. On the other hand, the process of benefit finding, especially the attainment and 
maintenance of benefits, may protect against the development of depressive symptoms. In the 
current study, trajectories of benefit finding and courses of psychological symptoms were 
examined over the same period; thus, it is difficult to draw a firm conclusion regarding which 
argument is more valid. Future research is needed to closely examine this issue. Regarding 
anxiety symptoms, a similar, parallel downward trend of anxiety symptoms was observed for 
all benefit finding trajectories during psychological care. This indicates that the process of 




           Several limitations should be taken into account when interpreting these findings. First, 
the current measure of benefit finding makes it difficult to obtain more detailed information 
regarding various domains of benefit finding such as changes in life priorities and spiritual 
beliefs (Tedeschi & Calhoun, 2004). Thus, it remains unknown whether there are differential 
benefit finding trajectories within these specific domains of benefit finding. Second, the 
follow-up time (nine months) was relatively short and consequently may not have been 
sufficient to detect substantial changes in benefit finding. Third, due to the lack of a control 
group, it remains unclear whether the observed differential processes of benefit finding were 
due to psychological care or changes associated with natural adaptation. Therefore, no 
conclusions can be drawn regarding the effectiveness of psychological care with respect to 
these distinct benefit finding trajectories. Finally, the majority of people in the present sample 
were highly educated, middle-aged females who had been diagnosed with breast cancer and 
had sought and received psychological care. Thus, these findings cannot be generalized to the 
general cancer population.  
          Despite these limitations, the present study shows that people with cancer followed 
different trajectories of benefit finding while receiving psychological care, and that only a 
small proportion experienced clinically meaningful increases in benefit finding over time. 
These findings contribute to the existing literature on benefit finding by demonstrating 
differential processes of benefit finding in people with cancer who are receiving 
psychological care. Moreover, this study adds to previous trajectory studies on negative 
outcomes reported by people with cancer (e.g., distress), and confirms that there are also 
subgroups of people with cancer with distinct trajectories of positive outcomes over time 
(Henselmans et al., 2010; Lam et al., 2010). This warrants further research on this topic in 
people with cancer as well as survivors of other kinds of trauma.  
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